Turning Point Therapeutics, Inc. (TPTX) has 20 known insider and institutional holders on record. The largest holder is Cormorant Asset Management, LP with 3,122,367 shares. Other notable holders include GLAXOSMITHKLINE PLC and Cui Jingrong Jean.
TPTX Insider Ownership
Top Holder
Cormorant Asset Management, LP
3,122,367 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Cormorant Asset Management, Lp |
10 Percent Owner |
3,122,367 |
2019-05-16 |
|
| 2 |
Glaxosmithkline Plc |
Director |
2,253,660 |
2020-05-26 |
|
| 3 |
Cui Jingrong Jean |
Director |
540,383 |
2020-06-10 |
|
| 4 |
Johnson Craig A |
V.p. Finance, CFO & Secretary |
250,000 |
2009-02-05 |
|
| 5 |
Sun Brian |
SVP & General Counsel |
195,000 |
2022-04-12 |
|
| 6 |
Sabus Steve M |
SVP & Chief Commercial Officer |
165,000 |
2022-06-01 |
|
| 7 |
Countouriotis Athena |
President & CEO |
47,930 |
2022-02-11 |
|
| 8 |
Tombesi Paolo |
EVP & Chief Financial Officer |
28,700 |
2022-07-29 |
|
| 9 |
Partridge Andrew John |
EVP & Chief Commercial Officer |
22,078 |
2022-02-11 |
|
| 10 |
Bodem Barbara W. |
Director |
14,995 |
2021-04-01 |
|
| 11 |
Alta Partners |
Other: Former 10% Owner |
12,056 |
2009-09-08 |
|
| 12 |
Alta Partners Iii, Inc. |
Other: Former 10% Owner |
12,056 |
2009-09-08 |
|
| 13 |
North Annette |
EVP & General Counsel |
11,696 |
2022-02-11 |
|
| 14 |
Ratoff Steven B |
Director |
10,000 |
2008-06-23 |
|
| 15 |
Deleage Jean |
Director |
10,000 |
2008-06-20 |
|
| 16 |
Fisherman Jason S |
Director |
10,000 |
2008-06-23 |
|
| 17 |
Gujrathi Sheila |
Director |
8,500 |
2020-06-17 |
|
| 18 |
Nicholson Garry A |
Director |
8,500 |
2021-06-04 |
|
| 19 |
George Simeon |
Director |
8,500 |
2021-06-04 |
|
| 20 |
Gordon Carl L |
Director |
8,500 |
2020-06-17 |
|
No ownership data available for TPTX.
